Complexity of Effector Mechanisms in Cyclosporine-Induced Syngeneic Graft-Versus-Host Disease

Biology of Blood and Marrow Transplantation

Volumn 6, Issue 1, 2000, Pages 13-24

  Hess, Allan D ^a   Thoburn, Christopher J ^a   Chen, Weiran ^a   Horwitz, Louis R ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Clonal analysis; Cytokine profile; Syngeneic graft versus host disease

Indexed keywords

CYCLOSPORIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; MESSENGER RNA;

ANIMAL; ARTICLE; BONE MARROW TRANSPLANTATION; CD8+ T LYMPHOCYTE; CELL CLONE; CHEMICALLY INDUCED DISORDER; COCULTURE; DOWN REGULATION; FEMALE; GENETICS; GRAFT VERSUS HOST REACTION; IMMUNOLOGY; ISOGRAFT; LEWIS RAT; PATHOLOGY; PHYSIOLOGY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECRETION; TIME; TRANSPLANTATION;

ANIMALS; BONE MARROW TRANSPLANTATION; CD8-POSITIVE T-LYMPHOCYTES; CLONE CELLS; COCULTURE TECHNIQUES; CYCLOSPORINE; CYTOKINES; DOWN-REGULATION; FEMALE; GRAFT VS HOST DISEASE; INTERFERON TYPE II; INTERLEUKIN-2; RATS; RATS, INBRED LEW; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TRANSPLANTATION, ISOGENEIC;

EID: 0033628094     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1083-8791(00)70048-6     Document Type: Article

References (42)

1. Glazier A, Tutschka PJ, Farmer ER, Santos GW. Graft-versus-host disease in cyclosporin A treated rats after syngeneic and autologous bone marrow reconstitution. J Exp Med. 1983;158:1.
2. Hess AD, Thoburn CJ. Immunobiology and immunotherapeutic implications of syngeneic/autologous graft-vs-host disease. Immunol Res. 1997;157:111.
3. Glazier A, Tutschka PJ, Farmer ER. Studies on the immunobiology of syngeneic and autologous graft-versus-host disease in cyclosporine treated rats. Transplant Proc. 1983;15:3035.
4. Beschorner WE, Shin CA, Fischer A, Santos GW, Hess AD. Cyclosporine (CsA) induced pseudo-graft-vs-host disease (CIPGVHD) in the early post CsA period. Transplantation. 1988;46(suppl):112.
5. Beschorner WE, Tutschka PJ, Santos GW. Chronic GVHD in the rat chimera. I. Clinical presentation, hematology, histology, and immunopathology in the long term chimeras. Transplantation. 1982;33:393.
6. Jenkins MK, Schwartz RH, Pardoll DM. Effects of cyclosporine A on T cell development and clonal deletion. Science. 1988;241:1655.
7. Gao EK, Lo D, Cheney R, Kanagawa O, Sprent J. Abnormal differentiation of thymocytes in mice treated with cyclosporin A. Nature. 1988;336:176.
8. Fischer AC, Beschorner WE, Hess AD. Requirements for the induction and adoptive transfer of cyclosporine-induced syngeneic graft-vs-host disease. J Exp Med. 1989;169:1031.
9. Fischer AC, Laulis MK, Horwitz L, Beschorner WE, Hess AD. Host-resistance to cyclosporine induced syngeneic graft-vs-host disease. J Immunol. 1989;143:827.
10. Hess AD, Horwitz L, Beschorner WE, Santos GW. Development of graft-vs-host disease-like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation. I Development of cytotoxic T-lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity. J Exp Med. 1985;161:718.
11. Fischer AC, Ruvolo PP, Burt R, et al. Characterization of the autoreactive T cell repertoire in cyclosporine-induced syngeneic graft-versus-host disease: a highly conserved repertoire mediates autoaggression. J Immunol. 1995;154:3713.
12. Hess AD, Thoburn C, Horwitz L. Promiscuous recognition of major histocompatibility class II determinants in cyclosporine-induced syngeneic graft-versus-host disease. Transplantation. 1998;65:785.
13. Hess A, Thoburn C, Bright E, Horwitz L. Specificity of effector mechanisms in syngeneic graft-vs-host disease: recognition of the MHC class II invariant chain peptide (CLIP). Transplant Proc. 1997;29:725.
14. Chen W, Thoburn C, Hess AD. Characterization of the pathogenic autoreactive T cells in cyclsoporine-induced syngeneic graft-versus-host disease. J Immunol. 1998;161:7040.
15. Matzinger P. The JAM test: a simple assay for DNA fragmentation and cell death. J Immunol Methods. 1991;145:185.
16. Freisewinkel IM, Schench K, Koch N. The segment of the invariant chain that is critical for association with major histocompatibility complex class II molecules contains the sequence of a peptide eluted from class II polypeptides. Proc Natl Acad Sci U S A. 1993;90:9703.
17. Jung HC, Eckman L, Yang S-K, Panja A, Fierer J, Morczycka-Wroblewski E. Distinct array of proinflammatory cytokines in human colon epithelial cells in response to bacterial invasion. J Clin Invest. 1995;95:55.
18. Volc-Platzer B, Rappersberger K, Mosberger I, et al. Sequential immunohistologic analysis of the skin following allogeneic bone marrow transplantation. J Invest Dermatol. 1988;91:162.
19. Ashkenazi A, Dixit VM. Death receptors, signaling and modulation. Science. 1998;281:1305.
20. Salgame P, Abrams JS, Clayberger C, Goldstein H. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science. 1991;254:279.
21. Croft M, Carter L, Swain SL, Dutton RW. Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J Exp Med. 1994;180:1715.
22. Krenger W, Snyder KM, Byon JCH, Falzarano G, Ferrara JLM. Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease. J Immunol. 1995;155:585,
23. Fowler DII, Breglio J, Nagel G, Eckhaus MA, Gress RE. Allospecific CD8+ Tel and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease. J Immunol. 1996;157:4811.
24. Fowler DH, Kurasawa K, Husebekk A, Cohen PA, Gress RE. Cells of the Th2 cytokine phenotype prevent LPS-induced lethality during murine graft-versus-host reaction: regulation of cytokines and CD8+ lymphoid engraftment. J Immunol. 1994;152:1004.
25. Collins BH, Chari RS, Magee JC, et al. Mechanisms of injury in porcine livers perfused with blood of patients with fulminant hepatic failure. Transplantation. 1994;58:1162.
26. Bass H, Mosmann T, Strober S. Evidence for mouse Th1 and Th1 helper T cells in vivo: selective reduction of Th1 cells after total lymphoid irradiation. J Exp Med. 1989;170:1495.
27. Hafler DA, Weiner HL. Immunologic mechanisms and therapy in multiple sclerosis. Immunol Rev. 1995;144:75.
28. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 1993;75:263.
29. Groux H, O'Garra, Bigler M, et al. A CD4+ T cell subset inhibits antigen-specific T cell responses and prevents colitis. Nature. 1997;389:737.
30. Nicholson LB, Kuchroo VK. Manipulation of the Th1/Th2 balance in autoimmune disease. Curr Opin Immunol. 1996;8:837.
31. Hess AD, Fischer AC, Horwitz L, Bright EC, Laulis MK. Characterization of peripheral autoregulatory mechanisms that prevent development of cyclosporin-induced syngeneic graft-vs-host disease. J Immunol. 1994;153:400.
32. Hess AD, Horwitz L, Thoburn C. Immune tolerance to self-MHC class II antigens after bone marrow transplantation. Transplant Proc. 1999;31:688.
33. Boise LH, Minn AJ, Noel PJ, et al. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity. 1995;3:87.
34. Bar XF, Zhu J, Zhang GX, et al. IL-10 suppresses experimental autoimmune neuritis and down-regulates Th1-type immune responses. Clin Immunol Immunopathol. 1997;83:117.
35. Moller DR. Cells and cytokines involved in the pathogenesis of sarcoidosis. Sarcoid Vasc Diffuse Lung Dis. 1999;16:24.
36. Sale GE, Shulman HM, Hackman RC. Pathology of hematopoietic cell transplantation. In Thomas ED, Blume KG, Forman SJ, eds. Hematopoietic Cell Transplantation. Maiden, MA: Blackwell Science; 1999:24.
37. Parkman R. Clonal analysis of graft-vs-host disease. In: Burakoff SJ, Deeg HJ, eds. Graft-vs-Host Disease: Immunology, Pathophysiology, and treatment. New York: Marcel Dekker; 1990:51.
38. Ferrara JLM, Antin JH. The pathophysiology of graft-versus-host disease. In: Thomas ED, Blume KG, Forman SJ, eds. Hematopoietic Cell Transplantation. Malden, MA: Black-well Science; 1999:305.
39. Ochs LA, Blazar BR, Roy J, Rest EB, Weisdorf DJ. Cytokine expression in human cutaneous chronic graft-versus-host disease. Bone Marrow Transplant. 1996;17:1085.
40. Hess AD, Fischer AC, Beschorner WE. Effector mechanisms in cyclosporine A induced syngeneic graft-vs-host disease: role of CD4+ and CD8+ T lymphocytes subsets. J Immunol. 1990;140:526.
41. Bryson JS, Lake-Bullock H, Pflugh DL, Jennings DC, Stuart-Caywood BE. In vivo reactivity of T cell clones isolated from mice with syngeneic graft-vs-host disease. Bone Marrow Transplant. 1997;19:721.
42. Hess A, Ruvolo P, Fischer A, Horwitz L, Bright E, Thoburn C. Characterization of the Vα/Vβ autoreactive T cell repertoire in syngeneic graft-vs-host disease. Transplant Proc. 1997;29:709.